The Associate Director,GMTMarketing, willbe responsible fortheallmarketing activities ofan upcoming new launchproductin Japanworking closely with Brand Lead and other stakeholdersS/he willbe responsible formaking sure thelaunchreadiness andownthe development and execution ofstrategyincluding diseaseawareness, patientdiagnosis, branded communication, peer-to-peerprogramming, and non-personal promotion This is a highly strategic role that requires seasoned commercial acumen, scientific curiosity,and growth mindset. The role also requires close collaboration with Sales, Thought Leader Liaison, Medical Affairs, and other internalfunctions
Principal Responsibilities
Serve as aproductmanagerandalignthe organizationbehindbrand vision
Set the strategic direction for the brandandachieve itsrevenue targets
Continuously cultivate deep marketandcustomer insightstoenhance the strategy
Driveall aspects of marketingprogramsand tacticsfrom design to execution
Effectively communicate with field sales teams to implementprogramsand tactics
Engagethought leadersforinsights,speakingengagements, and othercommercialinitiatives
Defineandevaluaterelevantleading andperformance indicators for the brand
Work onthelong-term growth and development goals
Qualifications
Demonstratedexpertiseof marketingbiopharma brand(s) in Japan
Prior launch experiences, preferably in rare diseaseand/or specialty care
Deep and well-rounded commercial experience in biopharma industry (e.g.sales, marketing, market research, new product planning)
Demonstratedexpertisedeveloping sound brand strategies grounded incustomerinsights
Executional and operationalknow-howon marketing programs
Ability to communicate and collaborate effectively with diverse stakeholders
Scientific acumen and comfort with clinicallyorienteddialogue
Intellectual curiosityand growth mindset
Passion for making a positive contribution to the rare disease community
Fluency in Japaneserequired;proficiencyin English ispreferred
Education
Bachelor’s degreerequired
Advanceddegree preferred(e.g.MBA, MS)
Date Posted
21-8月-2026
Closing Date
30-10月-2026
Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com Alexion participates in E-Verify.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy
